Azitra
Latest round
- Series B
Last raised
- Sep 2020
Total raised
- $34M
Investors
- 5
About Azitra
Azitra Inc.Founded in 2014 in Branford, US, Azitra Inc. specializes in developing dermatological therapeutics.00 mn.Azitra specializes in precision dermatology through the development of innovative therapeutics for treating adverse skin conditions. Its core products include engineered live biotherapeutic products and therapeutic proteins aimed at diseases like Netherton syndrome and ichthyosis vulgaris.Azitra generated revenue of USD 7,500 in 2024, with an EBITDA of USD -10,536,905.In June 2023, Azitra Inc.5 million shares at USD 5 per share, which will be used for clinical trials, product development, and general corporate purposes. The company plans to launch new products targeting skin conditions and expand its market presence in North America and Europe by the end of 2024.
Who invested in Azitra
5 investors across 3 rounds
See all investors in Azitra
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Azitra
Who invested in Azitra?
Azitra has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Azitra raised?
Azitra has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Azitra last raise money?
Azitra's most recent round on record is a Series B, in Sep 2020.
What does Azitra do?
Azitra is a biotechnology company.
Where is Azitra headquartered?
Azitra is headquartered in Branford, US.
Which VCs invest in companies like Azitra?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Azitra's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Azitra? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.